FDA Faces Controversy Over Drug Approvals, Vaccine Approach
The Food and Drug Administration (FDA) has experienced senior staff departures and criticism from industry groups and former commissioners since McCary took over in 2025.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
WTOP Washington DC
“FDA has seen senior staff departures and criticism since McCary took over last year. Broader changes are under review, though no acting commissioner named.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade